Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effects of Fenfluramine in Infants Aged 1 to Less Than 2 Years with Dravet Syndrome

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Germany Italy Spain
  • Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

    Not recruiting

    3 1 1
    Austria Belgium Bulgaria Croatia Czechia Finland +12
  • Study on Rituximab and Drug Combination for Treating Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

    Not recruiting

    3 1 1 1
    Austria Czechia Denmark Finland Germany Norway +1
  • Study on the Safety and Effects of SAR442501 for Children with Achondroplasia

    Not recruiting

    2 1 1
    Czechia Italy Spain
  • Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Poland Spain
  • Study on the Effects of Romosozumab and Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium France Germany Hungary Italy +3
  • Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Finland +12
  • Study on Linaclotide for Treating Functional Constipation in Children Aged 6 Months to Less Than 2 Years

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Germany Hungary
  • Study on the Safety and Pain Relief of Nasal Spray with Ketamine Hydrochloride and Sufentanil Citrate for Children with Moderate to Severe Pain

    Not recruiting

    2 1 1
    Investigated Diseases:
    Spain
  • Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany The Netherlands